methoxyhydroxyphenylglycol has been researched along with Cortical Lewy Body Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aerts, T; De Deyn, PP; Fransen, E; Gerritsen, MJ; Spikman, JM; Van Dam, D; van der Zee, S; van Laar, T; Vermeiren, Y | 1 |
| Aerts, MB; Bloem, BR; Claassen, JAHR; Esselink, RAJ; Herbert, MK; Kuiperij, HB; Spies, PE; Verbeek, MM | 1 |
| Abdo, WF; Aerts, MB; Bloem, BR; Claassen, JA; Esselink, RA; Verbeek, MM | 1 |
1 trial(s) available for methoxyhydroxyphenylglycol and Cortical Lewy Body Disease
| Article | Year |
|---|---|
CSF tau, Aβ42, and MHPG differentiate dementia with Lewy bodies from Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Female; Humans; Lewy Body Disease; Male; Methoxyhydroxyphenylglycol; Middle Aged; Peptide Fragments; Retrospective Studies; tau Proteins | 2011 |
2 other study(ies) available for methoxyhydroxyphenylglycol and Cortical Lewy Body Disease
| Article | Year |
|---|---|
Monoaminergic Markers Across the Cognitive Spectrum of Lewy Body Disease.
Topics: Aged; Biogenic Monoamines; Biomarkers; Cognition Disorders; Cognitive Dysfunction; Diagnosis, Differential; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Lewy Body Disease; Male; Methoxyhydroxyphenylglycol; Middle Aged; Parkinson Disease; Retrospective Studies | 2018 |
Addition of MHPG to Alzheimer's disease biomarkers improves differentiation of dementia with Lewy bodies from Alzheimer's disease but not other dementias.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Female; Humans; Lewy Body Disease; Logistic Models; Male; Methoxyhydroxyphenylglycol; Middle Aged; Peptide Fragments; Retrospective Studies; Sensitivity and Specificity; tau Proteins | 2014 |